Vergoeding 2016-2020 voor ATC-subgroep N06AB : Selectieve serotonine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| N06AB03 Fluoxetine (Prozac ®) | 804.000 | 782.850 | 818.750 | 998.350 | 1.516.700 |
| N06AB04 Citalopram (Cipramil ®) | 3.400.200 | 3.411.000 | 3.534.500 | 3.860.100 | 3.769.000 |
| N06AB05 Paroxetine (Seroxat ®) | 3.794.300 | 4.167.500 | 3.712.500 | 3.856.700 | 4.133.600 |
| N06AB06 Sertraline (Zoloft ®) | 1.902.200 | 2.022.100 | 1.995.700 | 2.021.100 | 2.047.100 |
| N06AB08 Fluvoxamine (Fevarin ®) | 825.900 | 762.810 | 752.020 | 753.500 | 744.370 |
| N06AB10 Escitalopram (Lexapro ®) | 1.680.200 | 1.320.400 | 1.461.000 | 1.696.500 | 2.023.800 |
| Totaal | 12.406.800 | 12.466.660 | 12.274.470 | 13.186.250 | 14.234.570 |